Pharma Focus Asia (PFA) reports facilitate to understand Pharma companies latest trends and insights. They enable to identify the facts, information of businesses, and to focus their resources on developing unique capabilities that could lead to a competitive advantage. Reports target underlying forces in the industry, the overall updates and the significant factors that establish a company's success within the industry.
The pharmacogenomics market in Asia is growing rapidly driven by several factors such as increasing demand for personalized medicine rising prevalence of chronic diseases and advancements in genomic technologies Pharmacogenomics is the study of how a persons genes affect their response to medication
Executive SummaryThe global varicella zoster infection tre
Market OverviewGlobal Drugs of Abuse Testing market revenue is expected to increase at a CAGR of during the forecast period In terms of revenue Immunoassay was the dominant Drug type segment in the global drugs of abuse testing market in The segment is expected to further gain traction owi
IntroductionPharmaceutical packaging also known as drug packaging involves various activities ranging from pharmaceutical production to distribution to the end user It helps in protecting the drugs and medicines from unfavorable environments such as physical damage biological contamination and degradation Improvement in the services of healthca...
The pharmaceutical industry in Singapore has strongly evolved owing to the highlyskilled biomedical workforce worldclass infrastructure and favorable government policy initiatives Nearly of the worlds top pharmaceutical firms have established their manufacturing and RD unit in Singapore to explore new strategic business opportunities and to introd...
Healthcare in India is undergoing transformation across the continuum Technology is redefining possibilities in healthcare delivery and expanding global industry leadership of biotech and pharma while seeking elusive solutions for sustainably addressing Indias needs Devices and diagnostics are moving into an era of growth driven by unmet clinical n...
